Bausch Lawsuit Submission Form

Company: Bausch Health Companies Inc.

Ticker: (NYSE) BHC

Deadline

Passed

Lead Plaintiff Deadline: September 25, 2023

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines.

WhatsApp

WhatsApp Channel QR Code

Scan the QR code or click the button to join.

Get Updates by Email

Subscribe for email notifications.

No spam, opt-out anytime, alert list is free.

Allegations

The complaint alleges that defendants made false and/or misleading statements about the Company’s spinoff of the Bausch + Lomb Corporation (“B+L”), including the benefits it would provide for Bausch shareholders and the effects it would have on Bausch post-spinoff. The complaint also alleges that the spinoff was done not to benefit shareholders but instead to undermine plaintiff lawsuits stemming from securities laws violations in 2016. Defendants’ statements about the B+L spinoff have caused significant damages for Bausch investors. On August 6, 2020, when the spinoff was announced, Bausch’s stock closed at $20.13 per share. The stock traded as high as $34.38 per share before falling to its current trading prices of under $10 per share.